Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2008 2
2009 2
2010 2
2013 1
2014 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.
Sarzotti-Kelsoe M, Bailer RT, Turk E, Lin CL, Bilska M, Greene KM, Gao H, Todd CA, Ozaki DA, Seaman MS, Mascola JR, Montefiori DC. Sarzotti-Kelsoe M, et al. J Immunol Methods. 2014 Jul;409:131-46. doi: 10.1016/j.jim.2013.11.022. Epub 2013 Dec 1. J Immunol Methods. 2014. PMID: 24291345 Free PMC article.
Measuring HIV neutralization in a luciferase reporter gene assay.
Montefiori DC. Montefiori DC. Methods Mol Biol. 2009;485:395-405. doi: 10.1007/978-1-59745-170-3_26. Methods Mol Biol. 2009. PMID: 19020839
Long-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccines.
Evans TG, Frey S, Israel H, Chiu J, El-Habib R, Gilbert P, Gaitan A, Montefiori DC; HIV Vaccine Trials Network (HVTN 803). Evans TG, et al. Vaccine. 2004 Jun 30;22(20):2626-30. doi: 10.1016/j.vaccine.2003.12.011. Vaccine. 2004. PMID: 15193388
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine.
Gilbert P, Wang M, Wrin T, Petropoulos C, Gurwith M, Sinangil F, D'Souza P, Rodriguez-Chavez IR, DeCamp A, Giganti M, Berman PW, Self SG, Montefiori DC. Gilbert P, et al. J Infect Dis. 2010 Aug 15;202(4):595-605. doi: 10.1086/654816. J Infect Dis. 2010. PMID: 20608874 Free PMC article. Clinical Trial.
Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1.
Platt EJ, Bilska M, Kozak SL, Kabat D, Montefiori DC. Platt EJ, et al. J Virol. 2009 Aug;83(16):8289-92. doi: 10.1128/JVI.00709-09. Epub 2009 May 27. J Virol. 2009. PMID: 19474095 Free PMC article.
Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.
Geonnotti AR, Bilska M, Yuan X, Ochsenbauer C, Edmonds TG, Kappes JC, Liao HX, Haynes BF, Montefiori DC. Geonnotti AR, et al. AIDS Res Hum Retroviruses. 2010 Mar;26(3):279-91. doi: 10.1089/aid.2009.0186. AIDS Res Hum Retroviruses. 2010. PMID: 20218881 Free PMC article.
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers.
Wang S, Kennedy JS, West K, Montefiori DC, Coley S, Lawrence J, Shen S, Green S, Rothman AL, Ennis FA, Arthos J, Pal R, Markham P, Lu S. Wang S, et al. Vaccine. 2008 Feb 20;26(8):1098-110. doi: 10.1016/j.vaccine.2007.12.024. Epub 2008 Jan 10. Vaccine. 2008. PMID: 18243434 Free PMC article. Corrected and republished. Clinical Trial.
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers.
Wang S, Kennedy JS, West K, Montefiori DC, Coley S, Lawrence J, Shen S, Green S, Rothman AL, Ennis FA, Arthos J, Pal R, Markham P, Lu S. Wang S, et al. Vaccine. 2008 Jul 23;26(31):3947-57. doi: 10.1016/j.vaccine.2007.12.060. Vaccine. 2008. PMID: 18724414 Free PMC article. Clinical Trial.
11 results
Jump to page
Feedback